ArticleDiabetes, obesity & metabolism2021

Association of estimated plasma volume and weight loss after long-term administration and subsequent discontinuation of the sodium-glucose cotransporter-2 inhibitor tofogliflozin.

Yasuhiro Matsubayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.